Logo image of TCBIO

TEXAS CAPITAL BANCSHARES - TCBI 5 3/4 PERP (TCBIO) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:TCBIO - US88224Q3056

21.17 USD
+0.02 (+0.09%)
Last: 11/25/2025, 3:20:43 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
TCBIO revenue by date.TCBIO revenue by date.
1.225B
35.09%
1.076B
-12.22%
932.346M
-13.31%
1.28B
37.29%
1.38B
7.81%
1.482B
7.39%
EBITDA
YoY % growth
TCBIO ebitda by date.TCBIO ebitda by date.
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
TCBIO ebit by date.TCBIO ebit by date.
N/A
4.93%
N/A
9.70%
N/A
2.73%
457.58M
27.62%
513.43M
12.21%
515.1M
0.33%
Operating Margin
TCBIO operating margin by date.TCBIO operating margin by date.
N/AN/AN/A35.75%37.21%34.76%
EPS
YoY % growth
TCBIO eps by date.TCBIO eps by date.
2.41
-47.49%
3.54
46.89%
4.31
21.75%
6.52
51.21%
7.24
11.11%
7.93
9.49%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
1.82
27.18%
1.45
58.08%
1.81
14.85%
1.97
-9.45%
1.89
3.98%
Revenue
Q2Q % growth
332.06M
17.05%
324.11M
15.56%
341.64M
11.12%
355.24M
4.37%
359.66M
8.31%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
125.52M
35.08%
106.01M
24.85%
126.29M
23.27%
137.54M
7.03%
140.37M
11.83%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
2.18
34.57%
1.810.3720.55%
Q2 2025
Q2Q % growth
1.58
97.50%
1.310.2720.50%
Q1 2025
Q2Q % growth
0.92
100.00%
0.99-0.07-6.76%
Q4 2024
Q2Q % growth
1.43
333.33%
1.100.3329.63%
Q3 2024
Q2Q % growth
1.62
37.29%
0.960.6668.72%
Q2 2024
Q2Q % growth
0.80
-39.85%
0.88-0.08-8.93%
Q1 2024
Q2Q % growth
0.46
-34.29%
0.61-0.15-24.46%
Q4 2023
Q2Q % growth
0.33
-15.38%
0.77-0.44-57.08%
Q3 2023
Q2Q % growth
1.18
59.46%
1.050.1312.74%
Q2 2023
Q2Q % growth
1.33
125.42%
0.970.3637.06%
Q1 2023
Q2Q % growth
0.70
1.45%
0.89-0.19-21.07%
Q4 2022
Q2Q % growth
0.39
-67.23%
0.96-0.57-59.50%
Q3 2022
Q2Q % growth
0.74
-2.63%
1.03-0.29-28.47%
Q2 2022
Q2Q % growth
0.59
-54.96%
0.71-0.12-17.31%
Q1 2022
Q2Q % growth
0.69
-48.12%
0.74-0.05-7.33%
Q4 2021
Q2Q % growth
1.19
4.39%
0.940.2527.18%
Q3 2021
Q2Q % growth
0.76
-29.63%
1.12-0.36-32.12%
Q2 2021
Q2Q % growth
1.31
279.45%
1.240.075.93%
Q1 2021
Q2Q % growth
1.33
450.00%
1.120.2118.91%
Q4 2020
Q2Q % growth
1.14
-19.72%
1.16-0.02-1.52%
Q3 2020
Q2Q % growth
1.08
-36.47%
0.600.4879.57%
Q2 2020
Q2Q % growth
-0.73
-148.67%
0.16-0.89-556.46%
Q1 2020
Q2Q % growth
-0.38
-123.75%
1.01-1.39-137.79%
Q4 2019
Q2Q % growth
1.42 1.54-0.12-7.53%
Q3 2019
Q2Q % growth
1.70 1.540.1610.42%
Q2 2019
Q2Q % growth
1.50 1.55-0.05-3.39%
Q1 2019
Q2Q % growth
1.60 1.380.2215.95%
TCBIO Yearly EPS VS EstimatesTCBIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
340.354M
171.56%
331.43M8.924M2.69%
Q2 2025
Q2Q % growth
307.464M
15.15%
305.14M2.324M0.76%
Q1 2025
Q2Q % growth
280.478M
9.42%
290.49M-10.012M-3.45%
Q4 2024
Q2Q % growth
283.681M
15.39%
288.89M-5.209M-1.80%
Q3 2024
Q2Q % growth
125.331M
-53.81%
258.74M-133.409M-51.56%
Q2 2024
Q2Q % growth
267.006M
-1.39%
272.58M-5.574M-2.04%
Q1 2024
Q2Q % growth
256.328M
-6.00%
258.35M-2.022M-0.78%
Q4 2023
Q2Q % growth
245.85M
-53.20%
257.81M-11.96M-4.64%
Q3 2023
Q2Q % growth
271.338M
2.62%
275.7M-4.362M-1.58%
Q2 2023
Q2Q % growth
270.776M
16.86%
275.55M-4.774M-1.73%
Q1 2023
Q2Q % growth
272.7M
33.81%
271.21M1.49M0.55%
Q4 2022
Q2Q % growth
525.3M
132.95%
279.31M245.99M88.07%
Q3 2022
Q2Q % growth
264.4M
22.81%
263.12M1.28M0.49%
Q2 2022
Q2Q % growth
231.7M
2.03%
225.73M5.97M2.64%
Q1 2022
Q2Q % growth
203.8M
-14.80%
218.1M-14.3M-6.56%
Q4 2021
Q2Q % growth
225.5M
-15.19%
219.64M5.86M2.67%
Q3 2021
Q2Q % growth
215.3M
-19.63%
229.12M-13.82M-6.03%
Q2 2021
Q2Q % growth
227.1M
-19.01%
244.23M-17.13M-7.01%
Q1 2021
Q2Q % growth
239.2M
-0.37%
255.92M-16.72M-6.53%
Q4 2020
Q2Q % growth
265.9M
0.11%
255.28M10.62M4.16%
Q3 2020
Q2Q % growth
267.9M
-1.69%
260.46M7.44M2.86%
Q2 2020
Q2Q % growth
280.4M
4.63%
243.93M36.47M14.95%
Q1 2020
Q2Q % growth
240.1M
-9.60%
258.01M-17.91M-6.94%
Q4 2019
Q2Q % growth
265.6M 262.59M3.01M1.15%
Q3 2019
Q2Q % growth
272.5M 271.48M1.02M0.38%
Q2 2019
Q2Q % growth
268M 273.19M-5.19M-1.90%
Q1 2019
Q2Q % growth
265.6M 260.44M5.16M1.98%
TCBIO Yearly Revenue VS EstimatesTCBIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-4.17% -3.57% 4.04% 14.26%
Revenue-1.85% -2.09% 0.47% 0.39%